{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:54:05Z","timestamp":1793832845710,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08130-8","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T09:43:40Z","timestamp":1746092620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Mannose inhibits PKM2 lactylation to induce pyroptosis in bladder cancer and activate antitumor immune responses"],"prefix":"10.1038","volume":"8","author":[{"given":"Haoyi","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8700-632X","authenticated-orcid":false,"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8555-7769","authenticated-orcid":false,"given":"Yu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"8130_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"8130_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.eururo.2017.03.030","volume":"72","author":"R Seiler","year":"2017","unstructured":"Seiler, R. et al. Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy. Eur. Urol. 72, 544\u2013554 (2017).","journal-title":"Eur. Urol."},{"key":"8130_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jare.2021.11.010","volume":"39","author":"S Liu","year":"2022","unstructured":"Liu, S., Chen, X. & Lin, T. Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives. J. Adv. Res. 39, 187\u2013202 (2022).","journal-title":"J. Adv. Res."},{"key":"8130_CR4","first-page":"11536","volume":"24","author":"G Facchini","year":"2020","unstructured":"Facchini, G. et al. Advanced\/metastatic bladder cancer: current status and future directions. Eur. Rev. Med. Pharmacol. Sci. 24, 11536\u201311552 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"8130_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1104\/pp.85.1.56","volume":"85","author":"CB Watkins","year":"1987","unstructured":"Watkins, C. B. & Frenkel, C. Inhibition of pear fruit ripening by mannose. Plant Physiol. 85, 56\u201361 (1987).","journal-title":"Plant Physiol."},{"key":"8130_CR6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.euf.2022.12.013","volume":"9","author":"S Salvatore","year":"2023","unstructured":"Salvatore, S. et al. A randomized controlled trial comparing a new D-mannose-based dietary supplement to placebo for the treatment of uncomplicated Escherichia coli urinary tract infections. Eur. Urol. Focus 9, 654\u2013659 (2023).","journal-title":"Eur. Urol. Focus"},{"key":"8130_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/jamainternmed.2024.0264","volume":"184","author":"G Hayward","year":"2024","unstructured":"Hayward, G. et al. d-mannose for prevention of recurrent urinary tract infection among women: a randomized clinical trial. JAMA Intern Med. 184, 619\u2013628 (2024).","journal-title":"JAMA Intern Med."},{"key":"8130_CR8","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41586-018-0729-3","volume":"563","author":"PS Gonzalez","year":"2018","unstructured":"Gonzalez, P. S. et al. Mannose impairs tumour growth and enhances chemotherapy. Nature 563, 719\u2013723 (2018).","journal-title":"Nature"},{"key":"8130_CR9","doi-asserted-by":"crossref","unstructured":"Harada, Y. et al. Metabolic clogging of mannose triggers dNTP loss and genomic instability in human cancer cells. eLife 12, e83870 (2023).","DOI":"10.7554\/eLife.83870"},{"key":"8130_CR10","doi-asserted-by":"crossref","unstructured":"Zhang, R. et al. D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1. Proc. Natl. Acad. Sci. USA 119, e2114851119 (2022).","DOI":"10.1073\/pnas.2114851119"},{"key":"8130_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188970","volume":"1878","author":"H Jin","year":"2023","unstructured":"Jin, H., Liu, X. & Liu, H. X. Biological function, regulatory mechanism, and clinical application of mannose in cancer. Biochim. Biophys. Acta Rev. Cancer 1878, 188970 (2023).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"8130_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 (2019).","journal-title":"Nature"},{"key":"8130_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41392-024-01918-w","volume":"9","author":"W Yao","year":"2024","unstructured":"Yao, W., Hu, X. & Wang, X. Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases. Signal. Transduct. Target Ther. 9, 232 (2024).","journal-title":"Signal. Transduct. Target Ther."},{"key":"8130_CR14","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.tem.2024.01.011","volume":"35","author":"Z Yang","year":"2024","unstructured":"Yang, Z., Zheng, Y. & Gao, Q. Lysine lactylation in the regulation of tumor biology. Trends Endocrinol. Metab. 35, 720\u2013731 (2024).","journal-title":"Trends Endocrinol. Metab."},{"key":"8130_CR15","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1016\/j.apsb.2021.02.006","volume":"11","author":"BE Burdette","year":"2021","unstructured":"Burdette, B. E., Esparza, A. N., Zhu, H. & Wang, S. Gasdermin D in pyroptosis. Acta Pharm. Sin. B 11, 2768\u20132782 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"8130_CR16","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41423-022-00905-x","volume":"19","author":"X Wei","year":"2022","unstructured":"Wei, X. et al. Role of pyroptosis in inflammation and cancer. Cell Mol. Immunol. 19, 971\u2013992 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"8130_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12929-023-00983-7","volume":"30","author":"V Arre","year":"2023","unstructured":"Arre, V. et al. The \u2018speck\u2019-tacular oversight of the NLRP3-pyroptosis pathway on gastrointestinal inflammatory diseases and tumorigenesis. J. Biomed. Sci. 30, 90 (2023).","journal-title":"J. Biomed. Sci."},{"key":"8130_CR18","doi-asserted-by":"publisher","first-page":"E538","DOI":"10.1073\/pnas.1520045113","volume":"113","author":"A Bhardwaj","year":"2016","unstructured":"Bhardwaj, A. & Das, S. SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions. Proc. Natl. Acad. Sci. USA 113, E538\u2013E547 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8130_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.molcel.2013.09.004","volume":"52","author":"L Lv","year":"2013","unstructured":"Lv, L. et al. Mitogenic and oncogenic stimulation of K433 acetylation promotes PKM2 protein kinase activity and nuclear localization. Mol. Cell 52, 340\u2013352 (2013).","journal-title":"Mol. Cell"},{"key":"8130_CR20","doi-asserted-by":"publisher","first-page":"e35571","DOI":"10.1097\/MD.0000000000035571","volume":"102","author":"S Zhang","year":"2023","unstructured":"Zhang, S., Liao, Z., Li, S. & Luo, Y. Non-metabolic enzyme function of PKM2 in hepatocellular carcinoma: a review. Medecine 102, e35571 (2023).","journal-title":"Medecine"},{"key":"8130_CR21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1126\/science.abl6324","volume":"377","author":"KS Robinson","year":"2022","unstructured":"Robinson, K. S. et al. ZAKalpha-driven ribotoxic stress response activates the human NLRP1 inflammasome. Science 377, 328\u2013335 (2022).","journal-title":"Science"},{"key":"8130_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/13697137.2019.1679110","volume":"23","author":"E Russo","year":"2020","unstructured":"Russo, E. et al. Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery. Climacteric 23, 201\u2013205 (2020).","journal-title":"Climacteric"},{"key":"8130_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.968739","volume":"12","author":"N Maalouf","year":"2022","unstructured":"Maalouf, N. et al. High mannose level in bladder cancer enhances type 1 fimbria-mediated attachment of uropathogenic E. coli. Front. Cell Infect. Microbiol. 12, 968739 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"8130_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201701398","volume":"7","author":"E Dalle Vedove","year":"2018","unstructured":"Dalle Vedove, E., Costabile, G. & Merkel, O. M. Mannose and mannose-6-phosphate receptor-targeted drug delivery systems and their application in cancer therapy. Adv. Health. Mater. 7, e1701398 (2018).","journal-title":"Adv. Health. Mater."},{"key":"8130_CR25","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","volume":"14","author":"M Liao","year":"2024","unstructured":"Liao, M. et al. Targeting the Warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer. Acta Pharm. Sin. B 14, 953\u20131008 (2024).","journal-title":"Acta Pharm. Sin. B"},{"key":"8130_CR26","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.molcel.2007.11.019","volume":"28","author":"T Hunter","year":"2007","unstructured":"Hunter, T. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol. Cell 28, 730\u2013738 (2007).","journal-title":"Mol. Cell"},{"key":"8130_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","volume":"17","author":"CD Allis","year":"2016","unstructured":"Allis, C. D. & Jenuwein, T. The molecular hallmarks of epigenetic control. Nat. Rev. Genet. 17, 487\u2013500 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"8130_CR28","doi-asserted-by":"crossref","unstructured":"Wang, D., Liu, X., Li, M., Ning, J. HIF-1alpha regulates the cell viability in radioiodine-resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2\/NF-kappaB signaling pathway. Mol. Carcinog. 63, 238\u2013252 (2023).","DOI":"10.1002\/mc.23648"},{"key":"8130_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106033","volume":"175","author":"N Li","year":"2022","unstructured":"Li, N., Wang, Y., Wang, X., Sun, N. & Gong, Y. H. Pathway network of pyroptosis and its potential inhibitors in acute kidney injury. Pharm. Res. 175, 106033 (2022).","journal-title":"Pharm. Res."},{"key":"8130_CR30","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/s41556-024-01491-y","volume":"26","author":"SM Man","year":"2024","unstructured":"Man, S. M. & Kanneganti, T. D. Innate immune sensing of cell death in disease and therapeutics. Nat. Cell Biol. 26, 1420\u20131433 (2024).","journal-title":"Nat. Cell Biol."},{"key":"8130_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/JU.0000000000003002","volume":"209","author":"HW Lee","year":"2023","unstructured":"Lee, H. W. et al. Clinical efficacy of neoadjuvant intravesical mitomycin-c therapy immediately before transurethral resection of bladder tumor in patients with nonmuscle-invasive bladder cancer: preliminary results of a prospective, randomized phase II study. J. Urol. 209, 131\u2013139 (2023).","journal-title":"J. Urol."},{"key":"8130_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccell.2024.11.003","volume":"43","author":"Y Qiu","year":"2025","unstructured":"Qiu, Y. et al. Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity. Cancer Cell 43, 103\u2013121.e108 (2025).","journal-title":"Cancer Cell"},{"key":"8130_CR33","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.7150\/ijbs.107256","volume":"21","author":"H Jin","year":"2025","unstructured":"Jin, H. et al. Mannose inhibits NSCLC growth and inflammatory microenvironment by regulating gut microbiota and targeting OGT\/hnRNP R\/JUN\/IL-8 Axis. Int. J. Biol. Sci. 21, 1566\u20131584 (2025).","journal-title":"Int. J. Biol. Sci."},{"key":"8130_CR34","doi-asserted-by":"crossref","unstructured":"Xing, Y. et al. A bifunctional lysosome\u2010targeting chimera nanoplatform for tumor\u2010selective protein degradation and enhanced cancer immunotherapy. Adv. Mater. 37, e2417942 (2025).","DOI":"10.1002\/adma.202417942"},{"key":"8130_CR35","doi-asserted-by":"publisher","first-page":"e1006752","DOI":"10.1371\/journal.pcbi.1006752","volume":"15","author":"A Malyutina","year":"2019","unstructured":"Malyutina, A. et al. Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer. PLoS Comput. Biol. 15, e1006752 (2019).","journal-title":"PLoS Comput. Biol."},{"key":"8130_CR36","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1074\/jbc.RA119.010838","volume":"295","author":"C Romero","year":"2020","unstructured":"Romero, C. et al. A cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors. J. Biol. Chem. 295, 2601\u20132613 (2020).","journal-title":"J. Biol. Chem."},{"key":"8130_CR37","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"8130_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201902880","volume":"7","author":"YR Miao","year":"2020","unstructured":"Miao, Y. R. et al. ImmuCellAI: a unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy. Adv. Sci. 7, 1902880 (2020).","journal-title":"Adv. Sci."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08130-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T09:43:44Z","timestamp":1746092624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08130-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8130"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08130-8","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal studies were approved by the Animal Care and Use Committee of China Medical University (IACUC Issue No. KT2023184, date: 04\/03\/2024), and all the animal handling procedures were conducted in accordance with the Basel Declaration. Organoid culture was approved by the local ethics committee of Liaoning Cancer Hospital& Institute (GZR20240373, date: 07\/03\/2024) based on the Helsinki Declaration, and written informed consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"689"}}